Fungal Meningitis Claims Settled For $100 Million
May 8, 2014
On May 6, 2014, a proposed $100 million settlement was filed in the U.S. Bankruptcy Court in Boston, Massachusetts regarding the claims of 3,300 claimants arising out of the allegedly contaminated steroid injections manufactured by the New England Compounding Center (“NECC”) that was loc[...]
Continue Reading
Accutane Retrial Results In $1.59M Verdict
March 13, 2014
On March 11, 2014, a New Jersey jury awarded $1.59 million (including about $88,000 in past medical expenses) to a woman who developed bowel disease (ulcerative colitis) as a result of using the acne medication, Accutane (isotretinoin), which was manufactured by Switzerland-based Roche Holding AG ([...]
Continue Reading
Drug Poisoning Is Leading Cause of Injury Deaths In U.S.
November 22, 2013
Drug poisoning deaths are now the leading cause of injury deaths in the United States, which have increased by more than 300% in the last 30 years, according to a new study published in the American Journal of Preventive Medicine. The increase has been seen in both urban areas and in rural areas,[...]
Continue Reading
How Does The FDA Review Proposed Drug Names?
November 5, 2013
The FDA’s Center for Drug Evaluation and Research (“CDER”) has received about 126,000 reports of medication errors from 2000 to 2009. Some of the medication errors were due to similarly sounding drugs or similarly appearing drug names. The CDER evaluates the potential for a prop[...]
Continue Reading
Study Finds Premarin Linked To Higher Risk Of Clots
October 2, 2013
A study published on September 30, 2013 in JAMA Internal Medicine found that women who were taking Premarin (conjugated equine estrogen) for menopause had double the risk (odds ratio, 2.08) of developing venous thrombosis (clots in the veins) than woman who took estradiol, both of which are oral es[...]
Continue Reading
Fireworks During Maryland ACTOS Trial
September 25, 2013
The Maryland wrongful death jury trial against the manufacturer of the diabetes drug Actos that began on September 3, 2013 in the Circuit Court for Baltimore City (only the second state Actos case to go to trial in the United States) is expected to conclude late next week yet it has resulted in [...]
Continue Reading
Maryland Actos Trial Underway
September 6, 2013
On September 3, 2013, a Baltimore City jury trial began in which the plaintiff alleges that the diabetes drug Actos was the cause of the bladder cancer that led to the death of a former U.S. Army translator in 2012. Actos is manufactured by Asia’s largest pharmaceutical manufacturer, Takeda P[...]
Continue Reading
